Summary by Moomoo AI
YICHANG EAST SUNSHINE CHANGJIANG PHARMACEUTICAL CO., LTD. (EAST SUNSHINE CHANGJIANG PHARMACEUTICALS) FILED ITS LATEST MONTHLY STATEMENT OF CHANGES IN SECURITIES WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 31 JANUARY 2024. The report shows that as of the end of January 2024, the total authorized/registered share capital of the company was RMB879,967,700, of which the number of H shares remained at 653,767,700 shares with an face value of RMB 1 per share, without increase or decrease. The equity portion was unchanged, with 226,200,000 shares outstanding. The report also confirms that the Company had no change in stock options, warrants, convertible notes or other related shares during the reporting period. The report was presented by the Joint Secretary of the Joint Undertaking, Peng Chi-yun, on 1 February 2024.